AbbVie's AL003 Rights Return to Alector (ALEC) 'No Major Suprise' - Mizuho
Tweet Send to a Friend
Mizuho Securities analyst Graig Suvannavejh reiterated a Buy rating and $15.00 price target on Alector Inc. (NASDAQ: ALEC) after the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
